ACE2 Polymorphisms and COVID-19 Severity: A Study on Their Relationship with Clinical Findings

Nilgün Çekin; Seyda Akin; Ergün PINARBAŞI; Halil Dogan

doi:10.1177/19450265261440903

April 7, 2026Genetic Testing and Molecular Biomarkers

ACE2 Polymorphisms and COVID-19 Severity: A Study on Their Relationship with Clinical Findings

View at Publisher

Ask AI

Bookmark

Share

Key Points

To examine the relationship between ACE2 polymorphisms and the severity of COVID-19.
Analysis of ACE2 rs140473595 polymorphism
Assessment of COVID-19 clinical findings
Comparison across different populations
Association between ACE2 rs140473595 and increased COVID-19 severity observed
Need for further studies to clarify ACE2 variants' roles in disease progression

Implication

Observational study correlates ACE2 genetic variants with COVID-19 severity, suggesting need for broader investigations.

Abstract

The ACE2 rs140473595 polymorphism is associated with COVID-19 severity. Broader studies in diverse populations are needed to further clarify the role of ACE2 variants in disease progression.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Çekin et al. (2026) studied this question.

synapsesocial.com/papers/69d895ea6c1944d70ce070d5 https://doi.org/10.1177/19450265261440903

View at Publisher

Ask AI

Bookmark

Share

ACE2 Polymorphisms and COVID-19 Severity: A Study on Their Relationship with Clinical Findings

Key Points

Implication

Abstract

Discussion

Cite This Study

ACE2 Polymorphisms and COVID-19 Severity: A Study on Their Relationship with Clinical Findings

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading